@article{01GT1XNV9VTXRW06Z47D4MT9Q6,
  abstract     = {{Introduction Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease and is influenced by sex hormones. Our aim was to investigate changes in visceral fat and the ratio of visceral fat to total body fat (VAT/TBF) and their associations with changes in lipids and insulin resistance after 1 year of hormone therapy in trans persons. Methods In 179 trans women and 162 trans men, changes in total body and visceral fat estimated with dual-energy X-ray absorptiometry before and after 1 year of hormone therapy were related to lipids and insulin resistance [homeostatic model assessment of insulin resistance (HOMA-IR)] with linear regression analysis. Results In trans women, total body fat increased by 4.0 kg (95% CI 3.4, 4.7), while the amount of visceral fat did not change (-2 grams; 95% CI -15, 11), albeit with a large range from -318 to 281, resulting in a decrease in the VAT/TBF ratio of 17% (95% CI 15, 19). In trans men, total body fat decreased with 2.8 kg (95% CI 2.2, 3.5), while the amount of visceral fat did not change (3 g; 95% CI -10, 16; range -372, 311), increasing the VAT/TBF ratio by 14% (95% CI 10, 17). In both groups, VAT/TBF was not associated with changes in blood lipids or HOMA-IR. Conclusions Hormone therapy in trans women and trans men resulted in changes in VAT/TBF, mainly due to changes in total body fat and were unrelated to changes in cardiometabolic risk factors, which suggests that any unfavorable cardiometabolic effects of hormone therapy are not mediated by changes in visceral fat or VAT/TBF.}},
  author       = {{Klaver, Maartje and  van Velzen, Daan and  de Blok, Christel and  Nota, Nienke and  Wiepjes, Chantal and Defreyne, Justine and  Schreiner, Thomas and  Fisher, Alessandra and  Twisk, Jos and  Seidell, Jaap and T'Sjoen, Guy and  den Heijer, Martin and  de Mutsert, Renee}},
  issn         = {{0021-972X}},
  journal      = {{JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM}},
  keywords     = {{lipids,insulin resistance,hormone therapy,transgender,visceral fat}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{E153--E164}},
  title        = {{Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy}},
  url          = {{http://doi.org/10.1210/clinem/dgab616}},
  volume       = {{107}},
  year         = {{2022}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: